TNFSF11 and breast carcinoma: It was further discovered that a higher serum RANKL/OPG level is a prognostic factor associated with breast cancer metastasis.394 Currently, two ongoing trials are investigating the potential of denosumab in combination with chemotherapy to promote tumor inhibition (Table 4).